T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage

Immunity

Volumn 7, Issue 3, 1997, Pages 387-399

  Carson, Richard T ^a   Vignali, Kate M ^a   Woodland, David L ^a,b   Vignali, Dario A A ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANTIBODY COMBINING SITE; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CARBOXY TERMINAL SEQUENCE; IMMUNOGENICITY; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINE PRODUCTION;

EID: 0030802693     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80360-X     Document Type: Article

References (56)

1. Allen, P.M., Strydom, D.J., and Unanue, E.R. (1984). Processing of lysozyme by macrophages: identification of the determinant recognized by two T-cell hybridomas. Proc. Natl. Acad. Sci. USA 81, 2489-2493.
2. k molecule. J. Immunol. 135, 368-373.
3. Allen, P.M., Matsueda, G.R., Evans, R.J., Dunbar, J.B., Marshall, G.R., and Unanue, E.R. (1987). Identification of the T-cell and la contact residues of a T-cell antigenic epitope. Nature 327, 713-715.
4. Arden, B., Clark, S.P., Kabelitz, D., and Mak, T.W. (1995). Mouse T-cell receptor variable gene segment families. Immunogenetics 42, 501-530.
5. Berzovsky, J.A. (1995). Designing peptide vaccines to broaden recognition and enhance potency. Ann. NY Acad. Sci. 754, 161-168.
6. Brown, J.H., Jardetzky, T.S., Gorga, J.C., Stern, L.J., Urban, R.G., Strominger, J.L., and Wiley, D.C. (1993). Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364, 33-39.
7. Chicz, R.M., Urban, R.G., Lane, W.S., Gorga, J.C., Stern, L.J., Vignali, D.A.A., and Strominger, J.L. (1992). Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 358, 764-768.
8. Chicz, R.M., Urban, R.G., Gorga, J.C., Vignali, D.A.A., Lane, W.S., and Strominger, J.L. (1993). Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 178, 27-47.
9. Chien, Y.-H., and Davis, M.M. (1993). How αβ T-cell receptors "see" peptide/MHC complexes. Immunol. Today 14, 597-602.
10. Cole, G.A., Hogg, T.L., and Woodland, D.L. (1994). The MHC class I-restricted T cell response to Sendai virus infection in C57BL/6 mice: a single immunodominant epitope elicits an extremely diverse repertoire of T cells. Int. Immunol. 6, 1767-1775.
11. Daly, K., Nguyen, P., Hankley, D., Zhang, W.J., Woodland, D.L., and Blackman, M.A. (1995). Contribution of the TCR α-chain to the differential recognition of bacterial and retroviral superantigens. J. Immunol. 155, 27-34.
12. b-restricted response to an influenza A virus nucleoprotein epitope. J. Immunol. 151, 2658-2666.
13. De Magistris, M.T., Alexander, J., Coggeshall, M., Altman, A., Gaeta, F.C.A., Grey, H.M., and Sette, A. (1992). Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell 68, 625-634.
14. Evavold, B.D., Sloan-Lancaster, J., and Allen, P.M. (1993). Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. Immunol. Today 14, 602-609.
15. b. Science 257, 919-927.
16. Fremont, D.H., Hendrickson, W.A., Marrack, P., and Kappler, J.W. (1996). Structures of an MHC class II molecule with covalently bound single peptides. Science 272, 1001-1004.
17. Garbozi, D.N., Ghosh, P., Utz, U., Fan, Q.R., Biddison, W.E., and Wiley, D.C. (1996). Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384, 134-141.
18. Garcia, K.C., Degano, M., Stanfield, R.L., Brunmark, M.R., Jackson, M.R., Peterson, P.A., Teyton, L., and Wilson, I.A. (1996). An αβ T cell receptor structure at 2.5Å and its orientation in the TCR-MHC complex. Science 274, 209-219.
19. d. Science 256, 1817-1820.
20. Jameson, S.C., Carbone, F.R., and Bevan, M.J. (1993). Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. J. Exp. Med. 177, 1541-1550.
21. Jorgensen, J.L., Esser, U., de St Groth, B.F., Reay, P.A., and Davis, M.M. (1992). Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics. Nature 355, 224-230.
22. Kozono, H., White, J., Clements, J., Marrack, P., and Kappler, J. (1994). Production of soluble MHC class II proteins with covalently bound single peptides. Nature 369, 151-154.
23. Latron, F., Pazmany, L., Morrison, J., Moots, R., Saper, M.A., McMichael, A., and Strominger, J.L. (1992). A critical role for conserved residues in the cleft of HLA-A2 in presentation of a nonapeptide to T cells. Science 257, 964-967.
24. Madden, D.R., Gorga, J.C., Strominger, J.L., and Wiley, D.C. (1992). The three-dimensional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC. Cell 70, 1035-1048.
25. Madden, D.R., Garbozi, D.N., and Wiley, D.C. (1993). The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 75, 693-708.
26. Madrenas, J., Wange, R.L., Wang, J.L., Isakov, N., Samelson, L.E., and Germain, R.N. (1995). z phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science 267, 515-518.
27. Matsumura, M., Fremont, D.H., Peterson, P.A., and Wilson, I.A. (1992). Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 257, 927-934.
28. Moreno, J., Vignali, D.A.A., Nadimi, F., Fuchs, S., Adorini, L., and Hammerling, G.J. (1991). Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen. J. Immunol. 147, 3306-3313.
29. Muller, C.P., Ammerlaan, W., Fleckenstein, B., Krauss, S., Kalbacher, H., Schneider, F., Jung, G., and Wiesmuller, K.H. (1996). Activation of T cells by the ragged tail of MHC class II-presented peptides of the measles virus fusion protein. Int. Immunol. 8, 445-456.
30. Nardin, G.A., Oliveira, G.A., Calvo-Calle. J.M., and Nussenzweig, R.S. (1995). The use of multiple antigen peptides in the analysis and induction of protective immune responses against infectious diseases. Adv. Immunol. 60, 105-149.
31. k. Proc. Natl. Acad. Sci. USA 89, 7380-7383.
32. Nelson, C.A., Petzold, S.J., and Unanue, E.R. (1993). Identification of two distinct properties of class II major histocompatibility complex-associated peptides. Proc. Natl. Acad. Sci. USA 90, 1227-1231.
33. Nelson, C.A., Petzold, S.J., and Unanue, E.R. (1994). Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell. Nature 371, 250-252.
34. k. J. Immunol. 157, 755-762.
35. Parra-Lopez, C.A., Lindner, R., Vidavsky, I., Gross, M., and Unanue, E.R. (1997). Presentation on class II MHC molecules of endogenous lysozyme targeted to the endocytic pathway. J. Immunol. 158, 2670-2679.
36. Rammensee, H.-G., Friede, T., and Stevanovic, S. (1995). MHC ligands and peptide motifs: first listing. Immunogenetics 41, 178-228.
37. Rotzschke, O., and Falk, K. (1992). Naturally-occurring peptide antigens derived from the MHC class-I-restricted processing pathway. Immunol. Today 12, 447-455.
38. Rudensky, A.Y., Preston-Hurlburt, P., Hong, S.-C., Barlow, A., and Janeway, C.A. Jr. (1991). Sequence analysis of peptides bound to MHC class II molecules. Nature 353, 622-627.
39. Sant'Angelo, D.B., Waterbury, G., Preston-Hurlbert, P., Yoon, S.T., Medzhitov, R., Hong, S.-C., and Janeway, C.A., Jr. (1996). The specificity and orientation of a TCR to its peptide-MHC class II ligands. Immunity 4, 367-376.
40. Sloan-Lancaster, J., Shaw, A., Rothbard, J., and Allen, P.M. (1994). Partial T cell signaling: altered phospho-ζ and lack of ZAP70 recruitment in APL-induced T cell anergy. Cell 79, 913-922.
41. Smilek, D.E., Wraith, D.C., Hodgkinson, S., Dwivedy, S., Steinman, L., and McDevitt, H.O. (1991). A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 88, 9633-9637.
42. Stern, L.J., and Wiley, D.C. (1994). Antigenicpeptide binding by class I and class II histocompatibility proteins. Structure 11, 245-251.
43. Stern, L.J., Brown, J.H., Jardetzky, T.S., Gorga, J.C., Urban, R.G., Strominger, J.L., and Wiley, D.C. (1994). Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368, 215-221.
44. b molecule. Immunity 3, 573-582.
45. Tomonari, K., Lovering, E., Fairchild, S., and Spencer, S. (1989). Two monoclonal antibodies specific for the T cell receptor Vα8. Eur. J. Immunol. 19, 1131-1135.
46. Townsend, A., and Bodmer, H. (1989). Antigen recognition by class I-restricted T lymphocytes. Annu. Rev. Immunol. 7, 601-624.
47. Townsend, A., Elliott, T., Cerundolo, V., Foster, L., Barber, B., and Tse, A. (1990). Assembly of MHC class I molecules analyzed in vitro. Cell 62, 285-295.
48. Urban, R.G., Chicz, R.M., Vignali, D.A.A., and Strominger, J.L. (1993). The dichotomy of peptide presentation byclass I and class II MHC proteins. In Naturally Processed Peptides, A. Sette, ed. (Basel: Karger), pp. 197-234.
49. Vidal, K., Hsu, B.L., Williams, C.B., and Allen, P.M. (1996). Endogenous altered peptide ligands can affect peripheral Tcell responses. J. Exp. Med. 183, 1311-1321.
50. Vignali, D.A.A., Moreno, J., Schiller, D., and Hammerling, G.J. (1992). Species-specific binding of CD4 to the β2 domain of major histocompatibilitycomplex class II molecules. J. Exp. Med. 175, 925-932.
51. Vignali, D.A.A., Urban, R.G., Chicz, R.M., and Strominger, J.L. (1993). Minute quantities of a single immunodominant epitope are presented as large nested sets by MHC class II molecules. Eur. J. Immunol. 23, 1602-1607.
52. Vignali, D.A.A., and Strominger, J.L. (1994a). Co-receptor function and the characteristics of MHC-bound peptides: a common link? Immunologist 2, 93-99.
53. Vignali, D.A.A., and Strominger, J.L. (1994b). Amino acid residues that flank core peptide epitopes and the extracellular domains of CD4 modulate differential signaling through the T cell receptor. J. Exp. Med. 179, 1945-1956.
54. Vignali, D.A.A., Carson, R.T., Chang, B., Mittler, R.S., and Strominger, J.L. (1996). The two membrane proximal domains of CD4 interact with the T cell receptor. J. Exp. Med. 183, 2097-2107.
55. Viner, N.J., Nelson, C.A., Deck, B., and Unanue, E.R. (1996). Complexes generated by the binding of free peptides to class II MHC molecules are antigenically diverse compared with those generated by intracellular processing. J. Immunol. 157, 2365-2368.
56. Woodland, D.L., Smith, H.P., Surman, S., Le, P., Wen, R., and Blackman, M.A. (1993). Major histocompatibility complex-specific recognition of Mls-1 is mediated by multiple elements of the T cell receptor. J. Exp. Med. 177, 433-42.